Join us May 20 in Carlsbad or via our live virtual stream! This CME conference will offer a comprehensive summary of new medications and clinical data pertaining to the management and treatment of atherosclerosis. Register now: https://t.co/GPVfY37zqg
The @US_FDA should require a postmarketing trial of high-dose icosapent ethyl (#Vascepa) vs corn oil in patients at risk for CV events to resolve the conflicting findings of the #STRENGTHTrial & #REDUCEIT trials on the potential health benefits of omega-3s https://t.co/hguRSwe8hb
I too hope this is a moment of ethical reckoning for health disparities in our country. Poignant words by the always thoughtful @NMHheartdoc on the effects of #COVID19 in African American communities https://t.co/D9HdOqhSi9
This may be one of the most important pieces of content @medscape has ever published. What if we are doing it wrong in the treatment of #COVID19? What if @cameronks is correct? https://t.co/Zd7ELk1vvQ
Thread
In my 7 days on one of our (now 12!) non ICU #COVID19 units, I admitted 58 patients for COVID rule out, of whom 50 tested positive. Two died (DNR), 2 went to hospice, and 5 went to the ICU. That is… not my typical gen med service week. Following, some clinical observations.